Sirona Biochem (CVE:SBM) Shares Down 18.8% – Should You Sell?

Sirona Biochem Corp. (CVE:SBMGet Free Report)’s stock price was down 18.8% during trading on Monday . The company traded as low as C$0.07 and last traded at C$0.07. Approximately 112,944 shares were traded during trading, an increase of 44% from the average daily volume of 78,445 shares. The stock had previously closed at C$0.08.

Sirona Biochem Stock Performance

The company has a quick ratio of 2.41, a current ratio of 0.34 and a debt-to-equity ratio of 219.21. The firm has a market capitalization of C$16.69 million, a PE ratio of -6.50 and a beta of -0.03. The firm has a 50-day moving average price of C$0.07 and a 200 day moving average price of C$0.06.

About Sirona Biochem

(Get Free Report)

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.

Read More

Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with MarketBeat.com's FREE daily email newsletter.